Opioids Situation Improves, But Workers’ Comp Pharmacy Faces New Challenges
In workers’ comp pharmacy management, opioids often get the lion’s share of attention, and for good reason. Continue reading.
In workers’ comp pharmacy management, opioids often get the lion’s share of attention, and for good reason. Continue reading.
Workers’ comp pharmacy costs represent approximately 18% of total medical spend. That translates to $5 billion in pharmacy spend nationwide.1 Most employers and payors utilize Pharmacy Benefit Managers (PBMs) which offer an excellent line of defense in managing these ever-increasing pharmacy costs. But PBMs, by design, only manage the pharmacy related aspects of a claim. What if you could extend the reach of your PBM by combining it with the knowledge, care and one-on-one delivery model used in case management? With a pharmacy nurse, you can.
Thanksgiving is coming, which means it’s time for our favorite podcast of the year: What are You Thankful for in Workers’ Comp?
Not so long ago, a “collision warning system” was defined as nothing more than “honking your horn.” While that analogue system still has its place, it is limited in its preventive measures, not to mention its potential for misuse. Fortunately, advancements in ADAS technology (Advanced Driver Assistance Systems) have greatly expanded our collision warning measures, but the industry has also been hard at work taking that technology a step further by enabling our cars to alert us—and each other—to real-time, dynamic information.
The RIMS 2020 Annual Conference is the largest event of the year for the risk management community.
The AASCIF 2020 Annual Conference will bring together state
Most illnesses or injuries progress well with traditional case management services. However, a small percentage of cases require more intense and careful management. Early intervention and proper procedure are imperative in the treatment of catastrophically injured people. Clinical situations that require catastrophic case management are characterized by diagnosis, complexity of treatment, and high dollar exposure.